Matched-cohort study comparing bioactive human split-thickness skin allograft plus standard of care to standard of care alone in the treatment of diabetic ulcers: A retrospective analysis across 470 institutions.
Journal
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
ISSN: 1524-475X
Titre abrégé: Wound Repair Regen
Pays: United States
ID NLM: 9310939
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
05
06
2019
revised:
16
09
2019
accepted:
18
09
2019
pubmed:
7
10
2019
medline:
29
6
2021
entrez:
7
10
2019
Statut:
ppublish
Résumé
This retrospective, matched-cohort study analyzed 1,556 patients with diabetic ulcers treated at 470 wound centers throughout the United States to determine the effectiveness of a cryopreserved bioactive split-thickness skin allograft plus standard of care when compared to standard of care alone. There were 778 patients treated with the graft in the treatment cohort, who were paired with 778 patients drawn from a pool of 126,864 candidates treated with standard of care alone (controls), by using propensity matching to create nearly identical cohorts. Both cohorts received standard wound care, including surgical debridement, moist wound care, and offloading. Logistic regression analysis of healing rates according to wound size, wound location, wound duration, volume reduction, exposed deep structures, and Wagner grade was performed. Amputation rates and recidivism at 3 months, 6 months, and 1 year after wound closure were analyzed. Diabetic ulcers were 59% more likely to close in the treatment cohort compared to the control cohort (p = 0.0045). The healing rate with the graft was better than standard of care across multiple subsets, but the most significant improvement was noted in the worst wounds that had a duration of 90-179 days prior to treatment (p = 0.0073), exposed deep structures (p = 0.036), and/or Wagner Grade 4 ulcers (p = 0.04). Furthermore, the decrease in recidivism was statistically significant at 3 months, 6 months, and 1 year, with and without initially exposed deep structures (p < 0.05). The amputation rate in the treatment cohort was 41.7% less than that of the control cohort at 20 weeks (0.9% vs. 1.5%, respectively). This study demonstrated that diabetic ulcers treated with a cryopreserved bioactive split-thickness skin allograft were more likely to heal and remain closed compared to ulcers treated with standard of care alone.
Identifiants
pubmed: 31587418
doi: 10.1111/wrr.12767
pmc: PMC6972994
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-89Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2019 The Authors. Wound Repair and Regeneration published by Wiley Periodicals, Inc. on behalf of by the Wound Healing Society.
Références
Wounds. 2016 Apr;28(4):119-25
pubmed: 27071139
Clin Podiatr Med Surg. 2018 Jul;35(3):357-365
pubmed: 29861018
Foot Ankle. 1981 Sep;2(2):64-122
pubmed: 7319435
Wound Repair Regen. 2017 Apr;25(2):192-209
pubmed: 28370796
Adv Wound Care (New Rochelle). 2018 Mar 1;7(3):77-94
pubmed: 29644145
Wounds. 2011 Jul;23(7):184-9
pubmed: 25879172
N Engl J Med. 2017 Jun 15;376(24):2367-2375
pubmed: 28614678
Int J Mol Sci. 2017 Apr 07;18(4):
pubmed: 28387714
Foot Ankle Spec. 2011 Feb;4(1):29-41
pubmed: 21135263
Adv Skin Wound Care. 2009 Jul;22(7):316-24
pubmed: 20375969
Wound Repair Regen. 2017 Aug;25(4):564-573
pubmed: 28756628
Diabetes Care. 2001 Jan;24(1):84-8
pubmed: 11194247
J Vasc Surg. 2015 Apr;61(4):939-44
pubmed: 25656592
Ostomy Wound Manage. 2014 Sep;60(9):26-38
pubmed: 25211605
Wound Repair Regen. 2017 May;25(3):354-365
pubmed: 28419657
Adv Skin Wound Care. 2016 Sep;29(9):399-406
pubmed: 27538107